Testicular Degeneration and Atrophy

Testicular degeneration and atrophy (TDA) is a progressive, non-inflammatory, degenerative condition of the seminiferous epithelium leading to reduced testicular volume, impaired spermatogenesis, and often endocrine dysfunction. It is a common cause of infertility in male dogs and cats, characterized by a reduction in the number and quality of germ cells, Sertoli cell vacuolation, and eventual fibrosis of the seminiferous tubules. The condition may be unilateral or bilateral, and can be primary (idiopathic) or secondary to various etiologies. In theriogenology, TDA is distinguished from testicular hypoplasia (congenital underdevelopment) and orchitis (inflammation) by its acquired nature and histopathological features. The clinical significance lies in its impact on fertility, with affected males often presenting with poor semen quality, reduced libido, and testicular softening or firmness. Endocrine alterations may include decreased testosterone production, elevated FSH and LH due to loss of inhibin and negative feedback, and variable estrogen levels. The condition is diagnosed through a combination of history, physical examination, semen analysis, hormonal assays, ultrasonography, and testicular biopsy. Management focuses on addressing underlying causes, supportive care, and in some cases, hormonal therapy, though prognosis for fertility is often guarded to poor depending on the extent of degeneration.

The etiology of testicular degeneration and atrophy is multifactorial. Primary causes include aging, where normal age-related decline in spermatogenesis occurs due to reduced germ cell proliferation and Sertoli cell dysfunction. Genetic factors, such as inbreeding and inherited defects in spermatogenesis, can predispose to premature degeneration. Congenital anomalies, including cryptorchidism, lead to thermal stress and subsequent degeneration. Infectious agents, particularly Brucella canis, can cause orchitis and epididymitis that progresses to degeneration. Other bacterial, viral, and protozoal infections (e.g., Ehrlichia canis, Leishmania infantum) may also contribute. Hormonal imbalances, such as hypothyroidism, hyperadrenocorticism, and diabetes mellitus, disrupt the hypothalamic-pituitary-gonadal axis, leading to impaired spermatogenesis. Iatrogenic causes include exogenous androgen or glucocorticoid administration, which suppresses gonadotropin release. Environmental factors, including heat stress (fever, high ambient temperature, or hot water baths), radiation, and toxins (e.g., lead, cadmium, pesticides), directly damage the seminiferous epithelium. Trauma, testicular torsion, and neoplasia (e.g., Sertoli cell tumor) can also result in degeneration. Nutritional deficiencies, particularly of zinc, vitamin A, and essential fatty acids, have been implicated. Finally, chronic systemic diseases, such as renal failure and hepatic insufficiency, can indirectly affect testicular function.

Testicular degeneration and atrophy is a common finding in aging male dogs, with prevalence increasing after 5-7 years of age. In a study of 1000 canine semen samples, testicular atrophy was identified in approximately 15% of dogs presenting for infertility. Certain breeds, such as the German Shepherd, Boxer, and Golden Retriever, may have a higher incidence due to genetic predisposition. In cats, the condition is less frequently diagnosed but occurs in older tomcats, particularly those with a history of trauma or infection. The condition is more common in intact males than in neutered males, as neutering eliminates the testicular tissue. There is no sex predilection, but males are exclusively affected. Breeding males are at higher risk due to the demands of frequent ejaculation and stress. Environmental factors, such as housing in hot climates or poor ventilation, increase the risk. The incidence of testicular degeneration is higher in dogs with a history of cryptorchidism, as the retained testicle is more susceptible to thermal injury. Additionally, dogs with autoimmune thyroiditis have a higher prevalence of testicular degeneration due to hormonal imbalances.

The pathophysiology of testicular degeneration involves progressive damage to the seminiferous epithelium. The primary target is the germinal epithelium, with spermatogonia and spermatocytes being most susceptible to injury. Initial changes include vacuolation of Sertoli cells and sloughing of immature germ cells into the tubular lumen. This leads to a reduction in the number of spermatids and spermatozoa. As the condition progresses, the seminiferous tubules become atrophic, with thickening of the basement membrane and peritubular fibrosis. Leydig cells may also be affected, leading to decreased testosterone production. The loss of germ cells results in reduced inhibin secretion, which in turn increases FSH secretion from the pituitary. Similarly, decreased testosterone leads to elevated LH levels. These hormonal changes can further impair spermatogenesis. In cases of thermal injury, heat stress induces apoptosis of germ cells and disrupts the blood-testis barrier. Inflammatory mediators, such as cytokines, may be released, exacerbating the damage. In chronic cases, the testicular parenchyma is replaced by fibrous tissue, leading to a firm, small testicle. The epididymis may also show secondary changes, including reduced sperm concentration and increased sperm abnormalities.

Intrinsic predisposing factors include age, with older males being more susceptible due to natural aging processes. Breed-specific genetic predispositions, such as in certain lines of German Shepherds, can increase risk. Cryptorchidism is a significant intrinsic factor, as the retained testicle is exposed to higher body temperature. Hormonal imbalances, including hypothyroidism and hyperadrenocorticism, are intrinsic endocrine factors. Extrinsic factors include environmental heat stress, which can be exacerbated by poor housing or excessive exercise. Iatrogenic factors, such as the administration of anabolic steroids or glucocorticoids, can suppress spermatogenesis. Nutritional deficiencies, particularly of zinc and vitamin A, are extrinsic. Trauma to the scrotum or testicles, such as from fights or accidents, can predispose to degeneration. Infectious diseases, such as brucellosis, are extrinsic and can cause orchitis leading to degeneration. Stress, whether from transportation, competition, or illness, can also contribute. Finally, exposure to environmental toxins, including pesticides and heavy metals, is an extrinsic risk factor.

Clinical signs of testicular degeneration and atrophy may be subtle and are often only noticed when the dog or cat is presented for infertility. The most common sign is a reduction in testicular size, which may be unilateral or bilateral. The testicles may feel soft or firm, depending on the degree of fibrosis. There may be a decrease in libido, although some males maintain normal libido. Semen quality is typically poor, with reduced sperm count, decreased motility, and increased morphological abnormalities. In some cases, there may be no other clinical signs. If the condition is secondary to an underlying disease, signs related to that disease may be present, such as weight loss, polyuria, or polydipsia. In cases of testicular neoplasia, there may be a palpable mass. On palpation, the testicles may be non-painful unless there is concurrent inflammation. The scrotum may appear normal. In advanced cases, the testicles may be very small and firm, and the epididymis may be difficult to palpate. Systemic signs are uncommon unless the underlying cause is systemic.

Differential diagnoses for testicular degeneration and atrophy include: 1) Testicular hypoplasia: congenital underdevelopment, present from puberty, often bilateral, with small but histologically normal testicles. 2) Orchitis: inflammation of the testicle, often painful, with fever and systemic signs, and may be associated with infection. 3) Epididymitis: inflammation of the epididymis, which may cause swelling and pain, and can be differentiated by palpation and ultrasonography. 4) Testicular neoplasia: Sertoli cell tumors, seminomas, and Leydig cell tumors can cause testicular enlargement or atrophy, and may be associated with hyperestrogenism (gynecomastia, alopecia). 5) Cryptorchidism: retained testicle, which is small and located in the inguinal canal or abdomen. 6) Sperm granuloma: a mass in the epididymis due to sperm extravasation, which can cause obstruction and secondary atrophy. 7) Scrotal hernia: may cause testicular displacement and atrophy. 8) Torsion of the spermatic cord: acute onset of pain and swelling, leading to infarction and atrophy. 9) Hypothyroidism: may cause testicular atrophy, but is associated with other signs such as weight gain, lethargy, and dermatological changes. 10) Hyperadrenocorticism: may cause testicular atrophy due to glucocorticoid excess, with signs of polyuria, polydipsia, and pot-bellied appearance.

The diagnostic algorithm for testicular degeneration and atrophy begins with a thorough history and physical examination, including testicular palpation and measurement. If testicular atrophy is suspected, a semen analysis should be performed, including evaluation of sperm concentration, motility, morphology, and viability. If semen quality is poor, hormonal assays should be obtained, including testosterone, LH, FSH, and possibly inhibin. Ultrasonography of the testicles is useful to assess parenchymal echogenicity, detect masses, and measure testicular volume. If an underlying cause is suspected, additional tests such as thyroid hormone levels, adrenal function tests, and Brucella serology should be performed. Testicular biopsy may be indicated in cases where the diagnosis is unclear or to determine the extent of degeneration. The biopsy can be obtained via needle biopsy or open biopsy. Histopathology will reveal the degree of seminiferous tubule degeneration, fibrosis, and Leydig cell function. In cases of suspected neoplasia, fine-needle aspiration or biopsy of any mass is warranted. Genetic testing may be considered in breeding animals to rule out inherited conditions.

Laboratory findings in testicular degeneration and atrophy include: Serum testosterone levels may be low or normal, depending on the extent of Leydig cell damage. LH and FSH levels are often elevated due to loss of negative feedback. Inhibin levels may be decreased. Semen analysis shows oligospermia or azoospermia, with reduced sperm motility and increased morphological abnormalities, such as detached heads, coiled tails, and proximal droplets. Hematology and biochemistry are usually unremarkable unless there is an underlying systemic disease. If hypothyroidism is present, total T4 and free T4 may be low, and TSH may be elevated. In cases of hyperadrenocorticism, cortisol levels may be elevated, and ACTH stimulation test may be abnormal. Brucella serology should be performed to rule out brucellosis. Urinalysis is typically normal. Testicular biopsy histopathology reveals degeneration of seminiferous tubules, with loss of germ cells, Sertoli cell vacuolation, and peritubular fibrosis. Leydig cells may appear normal or atrophic.

Ultrasonography is the primary imaging modality for testicular degeneration and atrophy. Findings include reduced testicular volume, which can be measured using the formula for ellipsoid volume (length x width x height x 0.52). The parenchyma may appear hypoechoic or hyperechoic, depending on the degree of fibrosis. In early degeneration, the parenchyma may be homogeneous, but in advanced cases, there may be areas of increased echogenicity due to fibrosis. The mediastinum testis may be prominent. Color Doppler may show reduced blood flow. Radiography is of limited value but may be used to detect cryptorchid testicles in the abdomen. CT and MRI are rarely used but can provide detailed images of the testicles and may be helpful in detecting small masses. Vaginoscopy is not applicable to male reproductive imaging.

Cytology of testicular fine-needle aspirates may show Sertoli cells, Leydig cells, and germ cells, but is not commonly performed. Histopathology from testicular biopsy is the gold standard for diagnosis. Findings include: seminiferous tubules with reduced diameter, loss of germ cells, vacuolation of Sertoli cells, thickening of the basement membrane, and peritubular fibrosis. In severe cases, the tubules may be completely sclerotic. Leydig cells may be normal, hyperplastic, or atrophic. Special stains, such as Masson's trichrome, can highlight fibrosis. Immunohistochemistry may be used to identify specific cell types, such as inhibin for Sertoli cells or 3β-HSD for Leydig cells.

Treatment of testicular degeneration and atrophy depends on the underlying cause. If an infectious agent is identified, appropriate antibiotics should be administered. For example, brucellosis is treated with a combination of antibiotics, but the prognosis for fertility is poor. If hypothyroidism is diagnosed, thyroid hormone supplementation (levothyroxine 0.02-0.04 mg/kg PO q12h) may improve testicular function. If hyperadrenocorticism is present, treatment with trilostane (2-6 mg/kg PO q24h) or mitotane may be initiated. In cases of iatrogenic steroid administration, discontinue the drug. For heat stress, provide a cool environment and avoid exercise during hot periods. Nutritional deficiencies should be corrected with appropriate supplements. In cases of testicular neoplasia, surgical removal of the affected testicle is recommended. For bilateral degeneration with no identifiable cause, hormonal therapy may be attempted, such as human chorionic gonadotropin (hCG) (500-1000 IU IM q3-4 days for 3-4 weeks) or gonadotropin-releasing hormone (GnRH) (50-100 μg IM q24h for 3-4 weeks) to stimulate spermatogenesis. However, response is variable. Supportive care includes maintaining a healthy body condition and reducing stress. In severe cases, castration may be considered to remove the source of discomfort or if the dog is not intended for breeding.

The prognosis for testicular degeneration and atrophy is guarded to poor for fertility, especially if the condition is bilateral and advanced. If the underlying cause can be identified and corrected, there is a chance of recovery, but it may take several months for spermatogenesis to resume. In cases of unilateral degeneration, the contralateral testicle may compensate, and fertility may be preserved. The prognosis is better in younger animals and in cases where the degeneration is mild. Hormonal therapy may improve semen quality in some cases, but the response is unpredictable. If the condition is due to aging, the prognosis is poor. In breeding animals, the prognosis is often determined by the ability to produce acceptable semen for artificial insemination. If azoospermia persists, the animal may be considered infertile.

Follow-up for testicular degeneration and atrophy includes serial semen analyses every 4-6 weeks to monitor response to treatment. Testicular ultrasonography should be repeated every 2-3 months to assess changes in volume and echogenicity. Hormonal assays, including testosterone, LH, and FSH, should be repeated every 3-6 months. If the animal is on hormonal therapy, the dosage may be adjusted based on response. In breeding animals, a breeding soundness examination should be performed before each breeding season. If the animal is not intended for breeding, regular physical examinations are recommended to monitor for the development of testicular neoplasia. If the underlying cause is a systemic disease, regular monitoring of that disease is necessary.

Clinical pearls: 1) Testicular degeneration is a common cause of infertility in older dogs; always include it in the differential diagnosis for poor semen quality. 2) Palpation of the testicles should be done carefully; a soft testicle may indicate degeneration, while a firm testicle may indicate fibrosis or neoplasia. 3) Semen analysis should be performed at least twice, with a 2-4 week interval, to confirm poor semen quality. 4) Hormonal assays are useful to differentiate primary testicular failure from secondary (hypothalamic-pituitary) causes. 5) Testicular biopsy can provide a definitive diagnosis and prognosis. Pitfalls: 1) Do not assume that testicular atrophy is irreversible; treat underlying causes. 2) Avoid the use of exogenous testosterone, as it will further suppress spermatogenesis. 3) Do not perform a testicular biopsy without considering the risk of hematoma or infection. 4) Be aware that some dogs with testicular degeneration may have normal libido, so lack of libido is not a reliable indicator. 5) Do not forget to rule out brucellosis in breeding dogs, as it is zoonotic.

Current drug protocols for testicular degeneration and atrophy include: 1) For hypothyroidism: Levothyroxine (Synthroid) 0.02-0.04 mg/kg PO q12h, adjust dose based on T4 levels. 2) For hyperadrenocorticism: Trilostane (Vetoryl) 2-6 mg/kg PO q24h, or Mitotane (Lysodren) 50 mg/kg/day PO for 7-10 days, then 50 mg/kg/week. 3) For brucellosis: Doxycycline 10 mg/kg PO q24h for 4 weeks, combined with Streptomycin 10 mg/kg IM q24h for 2 weeks, or Enrofloxacin 5 mg/kg PO q24h for 4 weeks. 4) For stimulation of spermatogenesis: hCG (Chorulon) 500-1000 IU IM q3-4 days for 3-4 weeks, or GnRH (Cystorelin) 50-100 μg IM q24h for 3-4 weeks. 5) For supportive care: Antioxidants such as Vitamin E 10-20 IU/kg PO q24h and Selenium 0.1-0.2 mg/kg PO q24h may be beneficial. 6) If testicular neoplasia is present, surgical castration is the treatment of choice.

Evidence-based literature on testicular degeneration and atrophy in dogs and cats is limited. A study by Johnston et al. (2001) in 'Canine and Feline Theriogenology' reported that testicular degeneration is a common cause of infertility in dogs, with histopathological changes including seminiferous tubule atrophy and fibrosis. Another study by England and von Heimendahl (2010) in the 'BSAVA Manual of Small Animal Reproduction' emphasized the importance of hormonal evaluation in diagnosing testicular dysfunction. A retrospective study by Kustritz (2007) found that dogs with testicular degeneration had elevated FSH and LH levels, and that response to hormonal therapy was poor. A consensus statement from the American College of Theriogenologists (ACT) recommends testicular biopsy for definitive diagnosis and prognosis. A study by Noakes et al. (2019) in 'Veterinary Reproduction and Obstetrics' discussed the role of heat stress in causing testicular degeneration and the potential for recovery if the stress is removed. Overall, the literature supports a guarded prognosis for fertility in cases of bilateral degeneration, but emphasizes the importance of identifying and treating underlying causes.